Overview

  • Product nameAnti-Stra6 antibody
    See all Stra6 primary antibodies
  • Description
    Goat polyclonal to Stra6
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Rat
    Predicted to work with: Mouse
  • Immunogen

    Synthetic peptide:

    QAFRKAALTSAKAN

    , corresponding to C terminal amino acids 653-665 of mouse (NP_033317.1) and rat (NP_001025095.1) Stra6

  • Positive control
    • Rat brain lysates

Properties

Applications

Our Abpromise guarantee covers the use of ab77616 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
ELISA
  • Application notesPeptide ELISA: Use at an assay dependent dilution. Antibody detection limit dilution 1/32000
    WB: Use at a concentration of 0.3 - 1 µg/ml. Predicted molecular weight: 74 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionMay act as a high-affinity cell-surface receptor for the complex retinol-retinol binding protein (RBP/RBP4). Acts by removing retinol from RBP/RBP4 and transports it across the plasma membrane, where it can be metabolized. This mechanism does not depend on endocytosis. Binds to RBP/RBP4 with high affinity. Increases cellular retinol uptake from the retinol-RBP complex.
    • Tissue specificityBroad expression. In adult eye expressed in sclera, retina, retinal pigment epithelium, and trabecular meshwork but not in choroid and iris.
    • Involvement in diseaseDefects in STRA6 are the cause of microphthalmia syndromic type 9 (MCOPS9) [MIM:601186]; also called Matthew-Wood syndrome or Spear syndrome. Microphthalmia is a clinically heterogeneous disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS9 is a rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia.
      Note=Mutations in STRA6 may be a cause of isolated colobomatous microphthalmia, a disorder of the eye characterized by an abnormally small ocular globe.
    • Cellular localizationCell membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • MCOPCB8 antibody
      • MCOPS9 antibody
      • PP14296 antibody
      • Stimulated by retinoic acid 6 homolog antibody
      • Stimulated by retinoic acid gene 6 protein homolog antibody
      • STRA6 antibody
      • STRA6_HUMAN antibody
      see all

    Anti-Stra6 antibody images

    • Anti-Stra6 antibody (ab77616) at 0.3 µg/ml + rat brain lysate (in RIPA buffer) at 35 µg
      Developed using the ECL technique

      Predicted band size : 74 kDa
      Observed band size : 85 kDa (why is the actual band size different from the predicted?)


      Exposure time : 1 hour

    References for Anti-Stra6 antibody (ab77616)

    ab77616 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab77616.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"